Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 51-75 of 949 matching filings.

Per page
25
Current page
3
SC 13G/A File 005-43603

SC 13G/A

Filing date
03 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-43603

SC 13G/A

Filing date
30 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jun 2023
Reporting date
29 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-35076

FORM PRE 14A

Filing date
16 Jun 2023
Reporting date
27 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-26520

FORM 8-A12G

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-43603

SC 13D/A

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SCOTT 06.15.23

Filing date
15 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jun 2023
Reporting date
08 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
09 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SD File 001-35076

FORM SD

Filing date
01 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-252847

FORM 424B5

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-268956

FORM S-8

Filing date
22 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .